![Vijay Chiruvolu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vijay Chiruvolu worked as the Senior Vice President of Process Development at Kite Pharma, Inc. He then served as the Chief Technical Officer at Instil Bio, Inc. from 2020 to 2022.
In 2023, he became the Chief Technology Officer at Turnstone Biologics Corp.
Dr. Chiruvolu holds an MBA from The Pennsylvania State University and a doctorate degree from The University of Nebraska-Lincoln.
| Sociétés | Poste | Fin |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Directeur Technique/Scientifique/R&D | 01/11/2024 |
| INSTIL BIO, INC. | Directeur Technique/Scientifique/R&D | 02/09/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nebraska-Lincoln
 The University of Nebraska-Lincoln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
